New psychoactive substances and the Internet: current situations and issues

What new psychoactive substances (NPS) are circulating in France? How are they used? Who uses them? What do we know about how dangerous they are? How can they be controlled? This issue of Tendances summarises what we know about these products.

The terms 'new psychoactive substances' and 'new synthetic substances' appeared in 2008 to describe a range of diverse substances that mimic the effects of various illegal substances (ecstasy, amphetamines, cocaine, cannabis, etc.). Other terms used such as designer drugs, research chemicals (RC) and legal highs respectively allude to their imitative aspect, the fact that they are artificially synthesised and their legal status.

The molecular structure of all these new psychoactive substances is close to that of the product they are "copying" without being identical. This circumvents the legislation, at least in the short term, because the new products are not immediately classified as narcotics as soon as they are developed.

With the number of such substances continuously growing and the number of users rising across Europe (including in France), the aim of this issue of Tendances is to review what is known about the subject, notably what is available, who are the users, how these products are being taken, health consequences and questions about the relevant French legislation.

Publication type
Tendances
No.
84
Publication date
Language
French
Author(s)
LAHAIE
Emmanuel
MARTINEZ
Magali
CADET-TAÏROU
Agnès
Edited by
OFDT
Number of pages
8
Products & addictions
New Psychoactive Substances
Themes
Supply and markets
Territories
France
Dispositif d'enquête et d'observation
Health alert system